MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis

Japanese Journal of Cancer Research

Volumn 91, Issue 5, 2000, Pages 492-498

  Li, Xiao Jun ^a   Murai, Mutsuhiko ^a   Koyama, Takashi ^a   Li, Xiao Jin ^b   Wang, Dong Yu ^a   Hashimoto, Kenji ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

MDM2; Oral carcinogenesis; P53

Indexed keywords

MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P53;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0034119880     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00972.x     Document Type: Article

References (33)

1. Vokes, E. E., Weichselhaum, R. R., Lippman, S. M. and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328, 184-194 (1993).
2. Prime, S. S., Eveson, J. W., Guest, P. G., Parkinson, E. K. and Paterson, I. C. Early genetic and functional events in the pathogenesis of oral cancer. Radial. Oncol. Invest., 5, 93-96 (1997).
3. Linzer, D. I. and Levine, A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17, 43-52 (1979).
4. Sarnow, P., Ho, Y. S., Williams, J. and Levine, A. J. Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell, 28, 387-394 (1982).
5. Werness, B. A., Levine, A. J. and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79 (1990).
6. Shindoh, M., Chiba, I., Yasuda, M., Saito, T., Funaoka, K., Kohgo, T., Amemiya, A., Sawada, Y. and Fujinaga, K. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer, 76, 1513-1521 (1995).
7. Momand, J., Zambetti, G. P., Olson, D. C., George, D. and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245 (1992).
8. Chen, J., Marechal, V. and Levine, A. J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol., 13, 4107-4114 (1993).
9. Wu, X., Bayle, J. H., Olson, D. and Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132 (1993).
10. Chen, J., Wu, X., Lin, J. and Levine, A. J. mdm-2 inhibits the GI arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol., 16, 2445-2452 (1996).
11. Haupt, Y., Barak, Y. and Oren, M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J., 15, 1596-1606 (1996).
12. Lundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P. and Finlay, C. A. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev., 11, 714-725 (1997).
13. Schmitz-Drager, B. J., Kushima, M., Goebell, P., Jax, T. W., Gerharz, C. D . Bultel, H., Schulz, W. A., Ebert, T. and Ackermann, R. p53 and MDM2 in the development and progression of bladder cancer. Eur. Urol., 32, 487-493 (1997).
14. Cordon-Cardo, C., Latres, E., Drobnjak, M., Oliva, M. R., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F. and Levine, A. J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res., 54, 794-799 (1994).
15. Ungar, S., Van de Meeren, A., Tammilehto, L., Linnainmaa, K., Mattson, K. and Gerwin, B. I. High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesotheliomu cell lines. Br. J. Cancer, 74, 1534-1540 (1996).
16. McCann, A. H., Kirley, A., Carney, D. N., Corbally, N., Magee, H. M., Keating, G. and Dervan, P. A. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Br. J. Cancer, 71, 981-985 (1995).
17. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E. and Collins, V. P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53, 2736-2739 (1993).
18. Girod, S. C., Cesarz, D., Fischer, U. and Krueger, G. R. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis. Anticancer Res., 15, 1453-1457 (1995).
19. Hermanek, P., Hutter, R. V. P., Sobin, L. H., Wagner, G. and Wittekind, Ch. "TMN Atlas 4th Edition 1997." pp. 5-63 (1997). Kanehara Publ., Tokyo.
20. Hongyo, T., Buzard, G. S., Calvert, R. J. and Weghorst. C. M. 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Rex., 21, 3637-3642 (1993).
21. Hsu, S. M., Raine, L. and Fanger, H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am. J. Clin. Pathol., 75, 816-821 (1981).
22. Martinez, J. C., Mateo, M., Sanchez-Beato, M., Villuendas, R., Orradre, J. L., Algara, P., Sanchez-Verde, L., Garcia, P., Lopez, C., Martinez, P. and Piris, M. A. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression. J. Pathol., 177, 27-34 (1995).
23. Rotter, V., Aloni-Grinstein, R., Schwartz, D., Elkind, N. B., Simons, A., Wolkowicz, R., Lavigne. M., Beserman, P., Kapon, A. and Goldfinger, N. Does wild-type p53 play a role in normal cell differentiation? Semin. Cancer Biol., 5, 229-236 (1994).
24. Qian, W., Hu, L. F., Chen, F., Wang, Y., Magnusson, K. P., Kashuba, E., Klein, G. and Wiman, K. G. Infrequent MDM2 gene amplification and absence of gross WAFI gene alterations in nasopharyngeal carcinoma. Eur. J. Cancer B. Oral Oncol., 31B, 328-332 (1995).
25. Marchetti, A., Buttitta, F., Girlando, S., Dalla Palma, P., Pellegrini, S., Fina, P., Doglioni, C., Bevilacqua, G. and Barbareschi, M. mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J. Pathol, 175, 31-38 (1995).
26. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T. S., La Thangue. N. B. and Kouzarides, T. Stimulation of E2F1/ DPI transcriptional activity by MDM2 oncoprotein. Nature, 375, 691-694(1995).
27. Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A. and Bradley, A. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc. Natl. Acad. Sci. USA, 95, 15608-15612 (1998).
28. Hao, X. P., Gunther, T., Roessner, A., Price, A. B. and Talbot, I. C. Expression of mdm2 and p53 in epithelial neoplasms of the colorectum. Mol. Pathol., 51, 26-29 (1998).
29. Rasidakis, A., Orphanidou, D., Kalomenidis, J., Papamichalis, G., Toumbis, M., Lamb-aditis, J., Sacharidou, A., Papastamatiou, H. and Jordanoglou, J. Expression of mdm-2 protein in neoplastic, preneoplastic, and normal bronchial mucosa specimens: comparative study with p53 expression. Hybridoma, 17, 339-345 (1998).
30. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell., 75, 495-505 (1993).
31. Olson, D. C., Marechal, V., Momand, J., Chen, J., Romocki, C. and Levine, A. J. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene, 8, 2353-2360 (1993).
32. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C. and Levine, A. J. Gain of function mutations in p53. Nat. Genet., 4, 42-46 (1993).
33. Zhang, W., Funk, W. D., Wright, W. E., Shay, J. W. and Deisseroth, A. B. Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene, 8, 2555-2559 (1993).